Picking up two supplement bottles with the same "500 mg" on the label can feel reassuringly straightforward—until you realize one says pomegranate extract and the other says urolithin A. That single line of text hides a major difference in what your body actually absorbs and uses. A 500 mg dose of a whole-plant powder is not the same as 500 mg of a purified molecule, especially when that molecule is a gut-derived postbiotic that many people cannot make efficiently from food.
Understanding the active ingredient—not just the total milligrams—is the difference between paying for ellagitannin precursors you may never convert, and paying for a studied form of urolithin A that your cells can take up directly. Here is what the labels won’t tell you at first glance.
What Does '500 mg' Actually Mean on a Supplement Label?
The number on the front of the bottle refers to the weight of the raw material stuffed into each capsule or serving—not the weight of the bioactive compound you hope is doing the work. For an herbal extract like pomegranate, that 500 mg might be a concentrated powder standardized to a certain percentage of polyphenols, but it remains a complex mix. For a synthesized or fermented compound like urolithin A, 500 mg typically means 500 mg of the isolated molecule itself. The same milligram count tells two completely different stories.
Under current FDA rules for dietary supplements, manufacturers are responsible for ensuring their products are accurately labeled and not adulterated, but the agency does not pre-approve supplement formulas or verify efficacy. That means a label can tout "500 mg pomegranate extract" or "500 mg urolithin A" and be truthful about what’s in the bottle, while leaving the consumer to decipher whether the ingredient will actually deliver a meaningful dose of the target active.
One practical takeaway: Milligrams describe contents, not results. A person looking for the muscle-related and mitochondrial benefits studied in clinical trials might scan the label for the word "extract" and mistakenly assume they’re getting the researched dose, when in reality they’re taking a precursor that depends on a highly variable digestive step. This gap between ingredient weight and active delivery is where many supplement comparisons break down.
Pomegranate Extract 500 mg: What Are You Really Getting?
Pomegranate extract supplies ellagitannins—large polyphenol molecules that are not absorbed intact. Your gut bacteria must first break them down into smaller urolithins, including urolithin A. This conversion is not guaranteed; research suggests that a significant portion of the population does not harbor the specific bacterial strains needed to perform this transformation efficiently. In those individuals, consuming pomegranate extract yields little to no urolithin A, regardless of how many milligrams are on the label.
According to thelongevitydose.com, even among people who do produce urolithins, the amount generated can vary widely—from undetectable to modest levels—based on diet, age, and microbiome composition. That makes pomegranate extract an indirect source at best. Some observational studies link pomegranate juice or extract intake to better health outcomes, but those cannot be equated with taking isolated urolithin A at the precise dose used in clinical trials.
What does 500 mg of pomegranate extract actually deliver? It depends on the standardization, but even if the product guarantees a certain ellagitannin content, the real urolithin A yield may be only a fraction of what a direct 500 mg urolithin A supplement provides—and in non-converters, it’s essentially zero. For someone chasing the specific mitochondrial benefits seen in human studies, the math doesn’t favor hoping for bacterial alchemy.
Urolithin A 500 mg: Direct Delivery of a Postbiotic
Urolithin A supplements skip the gut lottery. They deliver the finished molecule your cells can use, without requiring microbial conversion. Most of the human research on urolithin A has used 500 mg taken twice daily, for a total of 1,000 mg per day, and observed improvements in muscle endurance and mitochondrial biomarkers in middle-aged and older adults. The milestone Singh et al. (2022) trial, for example, tested Mitopure at that exact dosing schedule and reported statistically significant gains in leg muscle strength and exercise performance over 8 weeks.
This direct delivery matters especially for older adults, who experience declining mitochondrial efficiency and are also more likely to have less resilient gut microbiomes. Rather than banking on ellagitannin conversion, a person can take a known quantity of the compound that has demonstrated biological effects. That said, urolithin A is not a panacea; its benefits have been shown primarily in individuals with age-related mitochondrial decline, not in young, healthy populations. Two specific product approaches illustrate how label transparency and supporting ingredients can differ even when the core molecule is the same.
Fmlave® Premium Urolithin A 500mg Energy Supplement | with Resveratrol & Vitamin C
Fmlave® Premium Urolithin A 500mg Energy Supplement offers a straightforward formulation: 500 mg of urolithin A per serving, plus resveratrol and vitamin C. No proprietary blend obscures individual amounts, so you can confirm the urolithin A dose matches the level studied in clinical trials. The additions of resveratrol and vitamin C may provide antioxidant support, though the specific combination has not been tested in published human trials.
For someone wanting to replicate the research dose without paying for a brand that funded the studies, this product makes that comparison easy. The trade-off is that its efficacy is inferred from the broader urolithin A literature rather than direct evidence on the formulation itself—a common supplement scenario. Still, a clean label at the studied 500 mg dose per serving gives users a reliable way to avoid the variability of precursor-based products.
Mitopure (by Timeline Nutrition)
Mitopure is the supplement brand used in the Singh et al. (2022) trial, which remains the most cited human evidence for urolithin A’s effects on muscle strength and mitochondrial health. Each serving delivers 500 mg of urolithin A, taken twice daily in that study. The published results showed improvements in walking distance and leg muscle power, though it’s worth noting the trial was industry-funded and lasted only 8 weeks—so long-term outcomes are still being investigated.
This direct research backing makes Mitopure a reference point in discussions about urolithin A, but it comes at a cost: sources report around $120 per month. For individuals who prioritize using the exact product from the published trial, that may be a worthwhile price. Others may find that a transparent 500 mg urolithin A option from another brand, like the one above, fits their budget and needs while still aligning with the studied dosing regimen.
Risks, Side Effects, and What the Studies Don't Tell Us
Reported side effects in urolithin A trials have been mild—occasional bloating, nausea, or stomach upset—and no serious adverse events led to discontinuation in the short-term studies. However, the longest trial lasted only about 12 weeks. No data exists on what happens when someone takes urolithin A daily for years. That absence of long-term safety evidence is a real gap, especially for a compound that influences mitochondrial dynamics.
As a dietary supplement, urolithin A is not required to undergo FDA pre-market review for safety or efficacy, and potential drug interactions remain largely unexplored. At Hone Health, the discussion notes that individuals taking medications that affect mitochondrial function or those with certain health conditions should approach with caution and ideally consult a healthcare provider. The $120 monthly price tag—more for some brands—also raises a practical question: the investment may not make sense for younger people with normal mitochondrial function, since benefits were observed in older adults with measurable decline.
What the studies don’t tell us is whether urolithin A changes disease risk over decades, how it interacts with common prescription drugs, or whether cycling on and off is safer than continuous use. Until longer and broader research emerges, a person choosing this supplement is essentially betting on a promising but early-evidence compound.
Practical Considerations: How to Choose Between These Supplements
The first fork in the road is diet versus supplementation. Whole foods like pomegranates, walnuts, and berries contribute ellagitannins along with fiber, vitamins, and other polyphenols, and for general health, that dietary pattern is a sensible, well-supported approach. But if you’re specifically targeting mitochondrial decline and you know you are a poor urolithin A converter (or you simply want the dose used in studies), a direct supplement delivers a controlled amount without banking on gut bacteria.
Among urolithin A products, cost and transparency become the deciding factors. Mitopure offers the comfort of research-direct provenance but at a higher monthly cost. A product like Fmlave’s urolithin A provides the same 500 mg dose with added antioxidants and a non-proprietary label, often at a different price point. Neither is universally better; the right choice depends on your budget, how much you value research-pedigree, and whether you want the extra ingredients. Before adding any supplement, especially one affecting cellular energetics, a conversation with a healthcare professional can help weigh the unknowns against your personal health picture.
Frequently Asked Questions
Can I get enough urolithin A just from eating pomegranate?
It depends on your gut microbiome. Some people are “non-producers” who cannot convert ellagitannins into significant urolithin A at all, while others may generate modest amounts. Without testing, you cannot predict whether dietary sources will deliver the studied dose.
Is it safe to take 1,000 mg of urolithin A daily?
Short-term human trials have used up to 1,000 mg daily (500 mg twice a day) without major adverse events, as noted by thelongevitydose.com. Still, long-term safety beyond a few months is unstudied, so medical guidance remains advisable.
Why is urolithin A so expensive compared to pomegranate extract?
Urolithin A is typically produced via fermentation or precise synthesis, which is costlier than extracting a crude plant powder. With reported monthly costs around $120, you’re paying for a fully formed postbiotic, not a precursor that may never convert.